Peptide Library
A research-cited reference for the peptides people actually ask about. Every claim links to the published study behind it, every compound carries its FDA status and an evidence grade, and nothing here is for sale. This is the reference you read before you talk to a licensed provider.
15 compounds across 7 categories
Repair & recovery
3 compoundsFOR RESEARCH PURPOSES ONLY
BPC-157
Also known as: Body Protection Compound 157, PL 14736, PLD-116
A research reference for BPC-157, a pentadecapeptide with a large rodent literature on tissue repair and gut protection and almost no human evidence.
Last reviewed July 15, 2026
FOR RESEARCH PURPOSES ONLY
KPV
Also known as: Lys-Pro-Val, alpha-MSH 11-13, KPV tripeptide
A research reference for KPV, the three-amino-acid tail of alpha-MSH, with a coherent rodent colitis literature, a well-characterized transporter mechanism, and no human trial.
Last reviewed August 2, 2026
FOR RESEARCH PURPOSES ONLY
TB-500
Also known as: Thymosin Beta-4 fragment, TB4, N-acetylated LKKTETQ
A research reference for TB-500, a synthetic seven-amino-acid fragment of thymosin β4 that is routinely confused with the full protein whose clinical trials it did not participate in.
Last reviewed August 2, 2026
Metabolic & GLP-1
3 compoundsFOR RESEARCH PURPOSES ONLY
Retatrutide
Also known as: LY3437943, Triple hormone receptor agonist
A research reference for retatrutide, an investigational GIP/GLP-1/glucagon triple receptor agonist with striking phase 2 weight data, no approval anywhere, and an unfinished registrational programme.
Last reviewed August 2, 2026
Semaglutide
Also known as: GLP-1 receptor agonist, Ozempic, Wegovy, Rybelsus
A research reference for semaglutide, an FDA-approved GLP-1 receptor agonist with one of the largest randomized trial programmes in metabolic medicine, and real limits that the headlines skip.
Last reviewed August 2, 2026
Tirzepatide
Also known as: Dual GIP/GLP-1 receptor agonist, Mounjaro, Zepbound
A research reference for tirzepatide, an FDA-approved dual GIP/GLP-1 receptor agonist with the largest weight reductions yet reported in randomized obesity trials, and a shorter safety record than the numbers suggest.
Last reviewed August 2, 2026
Growth hormone axis
2 compoundsFOR RESEARCH PURPOSES ONLY
CJC-1295
Also known as: CJC-1295 with DAC, DAC:GRF, hGRF(1-29) albumin bioconjugate
A research reference for CJC-1295, a long-acting GHRH analog with two small human pharmacology studies showing raised GH and IGF-1 and no trial of any clinical outcome.
Last reviewed August 2, 2026
FOR RESEARCH PURPOSES ONLY
Ipamorelin
A research reference for ipamorelin, a selective growth-hormone secretagogue with solid rodent pharmacology, one human dose-ranging study, and one phase 2 trial that missed its endpoint.
Last reviewed August 2, 2026
Longevity & cellular
2 compoundsFOR RESEARCH PURPOSES ONLY
MOTS-c
Also known as: Mitochondrial open reading frame of the 12S rRNA-c, Mitochondrial-derived peptide MOTS-c
A research reference for MOTS-c, a mitochondria-encoded peptide with a strong mouse metabolic literature, real human biomarker data, and no published trial in which anyone has been given it.
Last reviewed August 2, 2026
NAD+
Also known as: Nicotinamide adenine dinucleotide, NAD
A research reference for NAD+, a coenzyme whose oral precursors have a real randomized-trial literature, and whose injected form has none.
Last reviewed August 2, 2026
Skin, hair & aesthetics
1 compoundSexual health
1 compoundRx hormone track
3 compoundsDHEA
Also known as: Dehydroepiandrosterone, Prasterone
A research reference for DHEA, an adrenal steroid precursor sold over the counter as a dietary supplement in the US, dispensed as an approved prescription product only in a local vaginal form and through compounding pharmacies, with randomized evidence that is positive in adrenal insufficiency and largely negative for the anti-aging claims it is best known for.
Last reviewed August 2, 2026
NP Thyroid
Also known as: Desiccated thyroid extract, Natural desiccated thyroid, Porcine thyroid extract
A research reference for NP Thyroid, a porcine desiccated thyroid extract that the FDA classifies as an unapproved biological product marketed without the required license, and that showed no advantage over levothyroxine on symptoms or cognition in two randomized crossover trials.
Last reviewed August 2, 2026
Testosterone
Also known as: Testosterone replacement therapy, TRT
A research reference for testosterone therapy, the one compound in this library with a large randomized trial literature, and a prescription hormone that requires a diagnosis, a prescriber, and ongoing lab monitoring.
Last reviewed August 2, 2026
How we grade evidence
Every compound page carries one of three grades, and so does every claim area on it, so you always know what kind of evidence sits behind a claim:
- Human RCT evidence
- Randomized controlled trials in humans, the strongest grade we assign.
- Animal studies only
- Published animal or preclinical data with no controlled human trials.
- Anecdotal reports only
- User reports and practice patterns with no published controlled data.
Every claim links to its PubMed or DOI source, never a vendor and never a blog. Every page shows the date we last reviewed the research behind it.
How we grade evidence documents the full rubric, how citations are verified, and where that process has limits. The Research Team page describes who reviews these pages and why there is no individual byline on this site.
Before you act on any of this
This page is educational only and is not medical advice. It does not diagnose, treat, or prescribe. Review it with a licensed provider before making any health decision. Peptide Health Lab does not sell peptides.
How we grade and verify evidence · Terms of Use · Privacy Policy
Ready to map compounds to your goals?
Open the Stack Builder